TOPICAL PHARMACEUTICAL FORMULATION
    1.
    发明授权
    TOPICAL PHARMACEUTICAL FORMULATION 有权
    局部用药物制剂

    公开(公告)号:EP2131813B1

    公开(公告)日:2012-08-08

    申请号:EP08709428.0

    申请日:2008-02-15

    IPC分类号: A61K9/00

    摘要: A composition for topical application of an NSAID comprises a solution or suspension of the NSAID in a carrier system comprising a polyhydric alcohol, a glycol ether and an ester of A higher fatty acid, the carrier system being present as a single phase at ambient temperatures. The NSATD may be diclofenac as diclofenac acid. The polyhydric alcohol may be a glycol such as isopropylene glycol and the glycol ether may be a diethylene glycol ether such as diethylene glycol monoethyl ether.

    COMPOSITION FOR PROMOTING VASCULAR SMOOTH MUSCLE RELAXATION
    2.
    发明公开
    COMPOSITION FOR PROMOTING VASCULAR SMOOTH MUSCLE RELAXATION 审中-公开
    组合物升职松弛平滑肌罐

    公开(公告)号:EP1978931A1

    公开(公告)日:2008-10-15

    申请号:EP07704988.0

    申请日:2007-01-23

    IPC分类号: A61K9/06 A61K47/10

    摘要: A composition for topical application to a part of the body comprises a local anaesthetic and optionally a vasodilator as active ingredient dissolved in a blend of volatile and non-volatile solvents of different solvating capacities for the active ingredient. The vasodilator may comprise glyceryl trinitrate and the local anaesthetic may comprises an anaesthetic of the aminoamide or aminoester type. The volatile solvent may comprise a mixture of water with a C1-C5 alcohol and the non-volatile solvent may comprise a polyhydric alcohol and optionally a glycol. A low-concentration vasodilator-containing composition is also described. The compositions allow a “virtual injection” of the active ingredient to be delivered transdermally without general systemic uptake.

    TOPICAL PHARMACEUTICAL FORMULATION
    3.
    发明公开
    TOPICAL PHARMACEUTICAL FORMULATION 有权
    局部用药物制剂

    公开(公告)号:EP2131813A2

    公开(公告)日:2009-12-16

    申请号:EP08709428.0

    申请日:2008-02-15

    IPC分类号: A61K9/00

    摘要: A composition for topical application of an NSAID comprises a solution or suspension of the NSAID in a carrier system comprising a polyhydric alcohol, a glycol ether and an ester of A higher fatty acid, the carrier system being present as a single phase at ambient temperatures. The NSATD may be diclofenac as diclofenac acid. The polyhydric alcohol may be a glycol such as isopropylene glycol and the glycol ether may be a diethylene glycol ether such as diethylene glycol monoethyl ether.